NEW YORK ─ Oxford Immunotec said on Monday that it has entered into a memorandum of understanding with Green Cross Medical Science (GCMS) and Mesdia to market its research-use-only T-SPOT Discovery SARS-CoV-2 kit in South Korea.
Under the agreement, GCMS will market and sell the kit, Mesdia will import it, and Oxford Immunotec Korea will provide overall support.
Financial and other terms of the agreement were not disclosed.